IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues-Reference-Cited by-同舟云学术

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Published:2023-02 Issue: Volume:159 Page:105349
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Garland Suzanne M.,Iftner Thomas,Cuschieri Kate,Kaufmann Andreas M,Arbyn Marc,de Sanjose Silvia,Poljak Mario,Dillner Joakim,Unger Elizabeth R.,Garland Suzanne M,Stanley Margaret,Moscicki Anna-Barbara,Woo Yin Ling,Bhatla Neerja,Chan Karen L.,Palefsky Joel,Giuliano Anna R,Kaufmann Andreas M,de Sanjose Silvia,Brotherton Julia M.L.,Feldman Sarah

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference37 articles.

1. WHO Director-general calls for all countries to take action to help end the suffering caused by cervical cancer [cited 2019. Available from: https://www.who.int/news/item/18-05-2018-who-dg-calls-for-all-countries-to-take-action-to-help-end-the-suffering-caused-by-cervical-cancer.

2. Papanicolaou (1883-1962): discoverer of the Pap smear;Tatsumura;Singapore Med. J.,2015

3. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice;Khan;J. Natl. Cancer Inst.,2005

4. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial;Ronco;Lancet Oncol.,2010

5. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer;Arbyn;Vaccine,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of an Isothermal Amplification HPV Assay on Self-Collected Vaginal Samples as Compared to Clinician-Collected Cervical Samples;Diagnostics;2023-10-24

2. No woman left behind: achieving cervical cancer elimination among women living with HIV;The Lancet HIV;2023-06

3. Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation;Infectious Agents and Cancer;2023-05-10

4. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore;Cancers;2023-03-16